The effect of unripe grape juice in the treatment of proteinuria: A randomized placebo-controlled clinical trial

Early Phase 1

Recruiting

• Conditions: Membranous Nephropathy.; Unspecified nephritic syndrome with focal and segmental glomerular lesions; N05.2

• Registration Number: IRCT20211206053292N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Membrane nephropathy or primary focal and segmental glomerulosclerosis
Willingness to collaborate in the study in patients
Age range 64-18 years

Exclusion Criteria

kidney Transplantation
pregnancy
lactation
Allergy or Asthma and other Allergies
herbal drug consumption from three months ago
addiction, Cigarettes, Alcohol and Shisha using
professional sport
diseases : chronic inflammatory disease (like Rheumatoid Arthritis ), Major Depression, Schizophrenia, Severe liver disease, cirrhosis, malignancies, severe infectious disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
24-hour protein content of urine. Timepoint: Before the intervention and 8 weeks after the start of the intervention. Method of measurement: Calorimeteri.

Secondary Outcome Measures

Name	Time	Method
Serum albumin content. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Measurements in the laboratory with standard materials and devices by the calorimetri method.